{
  "id": 12336765,
  "title": "Lycia seeks IPO for antibody degraders as TRexBio, Retension set terms",
  "url": "https://urgent.news/2026/10/06/lycia-seeks-ipo-for-antibody-degraders-as-trexbio-retension-set-terms",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-06T08:21:13.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/lycia-seeks-ipo-for-antibody-degrader-work-as-trexbio-retension-forge-ahead/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lycia Therapeutics, a protein degradation startup built around science out of the lab of Nobel laureate Carolyn Bertozzi, has filed for an initial public offering. Two other biotech companies are also advancing their own Nasdaq ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}